Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

Cited In for PubMed (Select 19688046)

1.

Inferring viral dynamics in chronically HCV infected patients from the spatial distribution of infected hepatocytes.

Graw F, Balagopal A, Kandathil AJ, Ray SC, Thomas DL, Ribeiro RM, Perelson AS.

PLoS Comput Biol. 2014 Nov 13;10(11):e1003934. doi: 10.1371/journal.pcbi.1003934. eCollection 2014 Nov.

2.

Unfolded protein response in hepatitis C virus infection.

Chan SW.

Front Microbiol. 2014 May 20;5:233. doi: 10.3389/fmicb.2014.00233. eCollection 2014. Review.

3.

Visualizing hepatitis C virus infection in humanized mice.

von Schaewen M, Ding Q, Ploss A.

J Immunol Methods. 2014 Aug;410:50-9. doi: 10.1016/j.jim.2014.03.006. Epub 2014 Mar 15. Review.

4.

Single cell analysis of HCV-infected patient hepatocytes: the science is no longer science fiction.

Sheahan TP, Rice CM.

Gastroenterology. 2013 Dec;145(6):1199-202. doi: 10.1053/j.gastro.2013.10.035. Epub 2013 Oct 29. No abstract available.

5.

Simultaneous detection of hepatitis C virus and interferon stimulated gene expression in infected human liver.

Wieland S, Makowska Z, Campana B, Calabrese D, Dill MT, Chung J, Chisari FV, Heim MH.

Hepatology. 2014 Jun;59(6):2121-30. doi: 10.1002/hep.26770. Epub 2014 Apr 25.

6.

Determining the cellular diversity of hepatitis C virus quasispecies by single-cell viral sequencing.

McWilliam Leitch EC, McLauchlan J.

J Virol. 2013 Dec;87(23):12648-55. doi: 10.1128/JVI.01602-13. Epub 2013 Sep 18.

7.

An inducible transgenic mouse model for immune mediated hepatitis showing clearance of antigen expressing hepatocytes by CD8+ T cells.

Cebula M, Ochel A, Hillebrand U, Pils MC, Schirmbeck R, Hauser H, Wirth D.

PLoS One. 2013 Jul 15;8(7):e68720. doi: 10.1371/journal.pone.0068720. Print 2013.

8.

Sustained hyperresponsiveness of dendritic cells is associated with spontaneous resolution of acute hepatitis C.

Pelletier S, Bédard N, Said E, Ancuta P, Bruneau J, Shoukry NH.

J Virol. 2013 Jun;87(12):6769-81. doi: 10.1128/JVI.02445-12. Epub 2013 Apr 10.

9.

Preclinical evaluation of an anti-HCV miRNA cluster for treatment of HCV infection.

Yang X, Marcucci K, Anguela X, Couto LB.

Mol Ther. 2013 Mar;21(3):588-601. doi: 10.1038/mt.2012.247. Epub 2013 Jan 8.

10.

Hepatitis B virus mRNA-mediated miR-122 inhibition upregulates PTTG1-binding protein, which promotes hepatocellular carcinoma tumor growth and cell invasion.

Li C, Wang Y, Wang S, Wu B, Hao J, Fan H, Ju Y, Ding Y, Chen L, Chu X, Liu W, Ye X, Meng S.

J Virol. 2013 Feb;87(4):2193-205. doi: 10.1128/JVI.02831-12. Epub 2012 Dec 5.

11.

Innate immune responses in hepatitis C virus infection.

Li K, Lemon SM.

Semin Immunopathol. 2013 Jan;35(1):53-72. doi: 10.1007/s00281-012-0332-x. Epub 2012 Aug 7. Review.

12.

Safe, long-term hepatic expression of anti-HCV shRNA in a nonhuman primate model.

Suhy DA, Kao SC, Mao T, Whiteley L, Denise H, Souberbielle B, Burdick AD, Hayes K, Wright JF, Lavender H, Roelvink P, Kolykhalov A, Brady K, Moschos SA, Hauck B, Zelenaia O, Zhou S, Scribner C, High KA, Renison SH, Corbau R.

Mol Ther. 2012 Sep;20(9):1737-49. doi: 10.1038/mt.2012.119. Epub 2012 Jun 26.

13.

A new evolutionary model for hepatitis C virus chronic infection.

Gray RR, Salemi M, Klenerman P, Pybus OG.

PLoS Pathog. 2012;8(5):e1002656. doi: 10.1371/journal.ppat.1002656. Epub 2012 May 3. No abstract available.

14.

In vitro characterization of the activity of PF-05095808, a novel biological agent for hepatitis C virus therapy.

Lavender H, Brady K, Burden F, Delpuech-Adams O, Denise H, Palmer A, Perkins H, Savic B, Scott S, Smith-Burchnell C, Troke P, Wright JF, Suhy D, Corbau R.

Antimicrob Agents Chemother. 2012 Mar;56(3):1364-75. doi: 10.1128/AAC.05357-11. Epub 2011 Dec 27.

15.

Innate host response in primary human hepatocytes with hepatitis C virus infection.

Yang D, Liu N, Zuo C, Lei S, Wu X, Zhou F, Liu C, Zhu H.

PLoS One. 2011;6(11):e27552. doi: 10.1371/journal.pone.0027552. Epub 2011 Nov 8.

16.

Sequential bottlenecks drive viral evolution in early acute hepatitis C virus infection.

Bull RA, Luciani F, McElroy K, Gaudieri S, Pham ST, Chopra A, Cameron B, Maher L, Dore GJ, White PA, Lloyd AR.

PLoS Pathog. 2011 Sep;7(9):e1002243. doi: 10.1371/journal.ppat.1002243. Epub 2011 Sep 1.

17.

Hepatitis C virus induces interferon-λ and interferon-stimulated genes in primary liver cultures.

Marukian S, Andrus L, Sheahan TP, Jones CT, Charles ED, Ploss A, Rice CM, Dustin LB.

Hepatology. 2011 Dec;54(6):1913-23. doi: 10.1002/hep.24580.

18.

Up-regulation of Hedgehog pathway is associated with cellular permissiveness for hepatitis C virus replication.

Choi SS, Bradrick S, Qiang G, Mostafavi A, Chaturvedi G, Weinman SA, Diehl AM, Jhaveri R.

Hepatology. 2011 Nov;54(5):1580-90. doi: 10.1002/hep.24576.

19.

Differential, type I interferon-mediated autophagic trafficking of hepatitis C virus proteins in mouse liver.

Desai MM, Gong B, Chan T, Davey RA, Soong L, Kolokoltsov AA, Sun J.

Gastroenterology. 2011 Aug;141(2):674-85, 685.e1-6. doi: 10.1053/j.gastro.2011.04.060. Epub 2011 May 6.

20.

Selection, optimization, and pharmacokinetic properties of a novel, potent antiviral locked nucleic acid-based antisense oligomer targeting hepatitis C virus internal ribosome entry site.

Laxton C, Brady K, Moschos S, Turnpenny P, Rawal J, Pryde DC, Sidders B, Corbau R, Pickford C, Murray EJ.

Antimicrob Agents Chemother. 2011 Jul;55(7):3105-14. doi: 10.1128/AAC.00222-11. Epub 2011 Apr 18.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk